Increased IL-17RA and IL-17RC in End-Stage COPD and the Contribution to Mast Cell Secretion of FGF-2 and VEGF

Respiratory Research

Volumn 18, Issue 1, 2017, Pages

  Roos, Abraham B ^a,b,c   Mori, Michiko ^a   Gura, Harpreet K ^d,e   Lorentz, Axel ^f   Bjermer, Leif ^g   Hoffmann, Hans Jürgen ^d,e   Erjefält, Jonas S ^a   Stampfli, Martin R ^b,h  

^a LUND UNIVERSITY   (Sweden)

^b MCMASTER UNIVERSITY   (Canada)

^c ASTRAZENECA R AND D   (Sweden)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e AARHUS UNIVERSITY   (Denmark)

^f UNIVERSITY OF HOHENHEIM   (Germany)

^g LUND UNIVERSITY   (Sweden)

^h MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE MARKER; CHYMASE; CYTOKINE; ERSOFERMIN; FC EPSILON RECEPTOR 1; FC RECEPTOR; FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR A; INTERLEUKIN 17RC; INTERLEUKIN RECEPTOR; STEM CELL FACTOR; TRYPTASE; UNCLASSIFIED DRUG; VASCULOTROPIN; IL17RA PROTEIN, HUMAN; IL17RC PROTEIN, HUMAN; INTERLEUKIN 17 RECEPTOR; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

B LYMPHOCYTE; CELLULAR DISTRIBUTION; CELLULAR SECRETION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE COURSE; END STAGE CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; IMMUNODETECTION; IMMUNOREACTIVITY; IN VITRO STUDY; LETTER; LUNG PARENCHYMA; MAST CELL; PROTEIN EXPRESSION; PROTEIN SECRETION; PULMONARY HYPERTENSION; RESPIRATORY EPITHELIUM; RNA TRANSCRIPTION; SUBMUCOSA; VASCULAR REMODELING; AGED; CASE REPORT; FEMALE; IMMUNOLOGY; LUNG; MALE; MIDDLE AGED; SECRETION (PROCESS); UPREGULATION;

AGED; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; LUNG; MALE; MAST CELLS; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-17; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 85015146327     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/s12931-017-0534-9     Document Type: Letter

References (10)

1. Roos AB, Sanden C, Mori M, Bjermer L, Stampfli MR, Erjefalt JS: IL-17A Is Elevated in End-Stage Chronic Obstructive Pulmonary Disease and Contributes to Cigarette Smoke-induced Lymphoid Neogenesis. Am J Respir Crit Care Med. 2015;191(11):1232-41.
2. Roos AB, Sethi S, Nikota J, Wrona CT, Dorrington MG, Sanden C, Bauer CM, Shen P, Bowdish D, Stevenson CS, et al. IL-17A and the Promotion of Neutrophilia in Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2015;192(4):428-37.
3. Andersson CK, Mori M, Bjermer L, Lofdahl CG, Erjefalt JS: Alterations in lung mast cell populations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;181(3):206-17.
4. Andersen HB, Holm M, Hetland TE, Dahl C, Junker S, Schiøtz PO, Hoffmann HJ. Comparison of short term in vitro cultured human mast cells from different progenitors - Peripheral blood-derived progenitors generate highly mature and functional mast cells. Journal of Immunological Methods. 2008;336(2):166-74.
5. Hoffmann HJ, Frandsen PM, Christensen LH, Schiotz PO, Dahl R. Cultured human mast cells are heterogeneous for expression of the high-affinity IgE receptor FcepsilonRI. Int Arch Allergy Immunol. 2012;157(3):246-50.
6. Zanini A, Chetta A, Saetta M, Baraldo S, D'Ippolito R, Castagnaro A, Neri M, Olivieri D. Chymase-positive mast cells play a role in the vascular component of airway remodeling in asthma. Journal of Allergy and Clinical Immunology. 2007;120(2):329-33.
7. Norrby K. Mast cells and angiogenesis. APMIS. 2002;110(5):355-71.
8. Onishi RM, Gaffen SL. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology. 2010;129(3):311-21.
9. Zanini A, Chetta A, Saetta M, Baraldo S, Castagnetti C, Nicolini G, Neri M, Olivieri D. Bronchial vascular remodelling in patients with COPD and its relationship with inhaled steroid treatment. Thorax. 2009;64(12):1019-24.
10. Takahashi H, Numasaki M, Lotze MT, Sasaki H. Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells. Immunology letters. 2005;98(2):189-93.